Leap Therapeutics, Amaze Holdings, and Salarius Pharmaceuticals are the 3 Penny Stocks to watch on November 13, 2025, based on TipRanks’ Penny Stock Screener tool. Penny stocks are defined as stocks that trade at or below $5 per share and have a market capitalization below $300 million.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The Penny Stock Screener enables investors to identify stocks using various filters such as Sector, Price Target Upside, Smart Score, Analyst Consensus, Dollar Volume, and Price Change.
We leveraged the tool to identify the top three penny stocks with the highest Dollar Volume as of market close on November 12, 2025. Dollar Volume refers to the total value of shares traded in a day, calculated by multiplying the number of shares traded by the stock’s price.
Leap Therapeutics (LPTX) – Leap Therapeutics is a biopharmaceutical company focused on developing treatments for cancer. On November 12, LPTX had a Dollar Volume of $1.61 billion, while its share price rocketed more than 368%.
The company’s stock jumped sharply after it announced several major updates. It plans to expand into digital asset investments while continuing its cancer drug research. As part of this rebranding, the company will change its name to “Cypherpunk Technologies” and trade under the ticker symbol “CYPH.”
Amaze Holdings (AMZE) – Amaze Holdings operates as an end-to-end, creator-powered commerce platform that offers tools for seamless product creation and advanced e-commerce solutions. Yesterday, AMZE had a Dollar Volume of $109.55 million, while its stock price dropped by nearly 17%.
Amaze’s shares fell despite announcing the acquisition of the assets of The Food Channel for $650,000, payable in the form of a convertible promissory note issued by Amaze. This purchase helps Amaze grow into new creator areas by combining its food creators with The Food Channel’s well-known brand to build a next-gen social commerce and entertainment platform.
Salarius Pharmaceuticals (SLRX) – Salarius Pharmaceuticals is clinical-stage pharmaceutical company focused on developing novel treatments for cancer. On Wednesday, SLRX had a Dollar Volume of $88.35 million, accompanied by a stock price gain of 17.4%.
The share price gain seems to be a reversal from Salarius’ massive drop of 51% recorded on November 11. The company announced an underwritten public offering, selling 2.51 million shares and special pre-funded warrants to buy another 2.15 million shares at $1.50 each, raising about $7 million. The funds will be used to develop Salarius’ and Decoy’s research programs, pay off some of Decoy’s debts, and cover other general business expenses.
To find more penny stocks like these, you can take a look at TipRanks’ Penny Stock Screener tool. It shows a list of all penny stocks, their price movement, and other vital data.